(ICAD) Icade - Overview

Sector: Real Estate | Industry: REIT - Diversified | Exchange: PA (France) | Market Cap: 1.507m EUR | Total Return: 6.1% in 12m

Stock Property Investment, Property Development, Urban Planning
Total Rating 30
Safety 32
Buy Signal -0.32
Market Cap: 1,746m
Avg Trading Vol: 2.50M EUR
ATR: 2.70%
Peers RS (IBD): 48.2
Risk 5d forecast
Volatility27.6%
Rel. Tail Risk-2.05%
Reward TTM
Sharpe Ratio0.28
Alpha-0.97
Character TTM
Beta-0.055
Beta Downside-0.805
Drawdowns 3y
Max DD39.22%
CAGR/Max DD-0.24
Description: ICAD Icade

Icade SA (ICAD) is a French real estate company operating as a diversified REIT. The company integrates property investment and development.

Icades business model focuses on urban development projects across France. This includes both direct property ownership and development for various stakeholders.

The company emphasizes sustainable and adaptable urban environments. Further research on platforms like ValueRay can provide detailed financial metrics and performance trends.

Headlines to Watch Out For
  • Commercial property rental income drives core revenue
  • Property development sales impact short-term earnings
  • Interest rate fluctuations affect property valuations
  • Regulatory changes in urban planning create development risks
  • Economic growth influences office and retail demand
Piotroski VR‑10 (Strict) 4.5
Net Income: -192.7m TTM > 0 and > 6% of Revenue
FCF/TA: 0.04 > 0.02 and ΔFCF/TA 4.65 > 1.0
NWC/Revenue: 11.74% < 20% (prev 74.81%; Δ -63.06% < -1%)
CFO/TA 0.08 > 3% & CFO 789.9m > Net Income -192.7m
Net Debt (3.54b) to EBITDA (528.6m): 6.69 < 3
Current Ratio: 1.33 > 1.5 & < 3
Outstanding Shares: last quarter (75.9m) vs 12m ago 0.20% < -2%
Gross Margin: 30.23% > 18% (prev 0.34%; Δ 2.99k% > 0.5%)
Asset Turnover: 28.18% > 50% (prev 25.58%; Δ 2.60% > 0%)
Interest Coverage Ratio: 0.98 > 6 (EBITDA TTM 528.6m / Interest Expense TTM 396.5m)
Altman Z'' 0.44
A: 0.04 (Total Current Assets 1.37b - Total Current Liabilities 1.03b) / Total Assets 9.56b
B: -0.01 (Retained Earnings -123.0m / Total Assets 9.56b)
C: 0.04 (EBIT TTM 388.1m / Avg Total Assets 10.19b)
D: -0.00 (Book Value of Equity -6.80m / Total Liabilities 5.66b)
Altman-Z'' Score: 0.44 = B
Beneish M 1.00
DSRI: 1.25 (Receivables 499.9m/386.5m, Revenue 2.87b/2.77b)
GMI: 1.14 (GM 30.23% / 34.39%)
AQI: 32.50 (AQ_t 0.85 / AQ_t-1 0.03)
SGI: 1.04 (Revenue 2.87b / 2.77b)
TATA: -0.10 (NI -192.7m - CFO 789.9m) / TA 9.56b)
Beneish M-Score: 15.90 (Cap -4..+1) = D
What is the price of ICAD shares? As of April 04, 2026, the stock is trading at EUR 19.36 with a total of 143,723 shares traded.
Over the past week, the price has changed by +7.45%, over one month by -0.50%, over three months by -6.62% and over the past year by +6.10%.
Is ICAD a buy, sell or hold? Icade has no consensus analysts rating.
What are the forecasts/targets for the ICAD price?
Wallstreet Target Price 21.4 10.3%
Analysts Target Price - -
ICAD Fundamental Data Overview as of 02 April 2026
Market Cap USD = 1.75b (1.51b EUR * 1.159 EUR.USD)
P/E Forward = 6.4767
P/S = 1.1269
P/B = 0.3786
P/EG = 2.8071
Revenue TTM = 2.87b EUR
EBIT TTM = 388.1m EUR
EBITDA TTM = 528.6m EUR
Long Term Debt = 3.27b EUR (from longTermDebt, last quarter)
Short Term Debt = 1.04b EUR (from shortTermDebt, last quarter)
Debt = 4.39b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.54b EUR (from netDebt column, last quarter)
Enterprise Value = 5.54b EUR (1.51b + Debt 4.39b - CCE 359.8m)
Interest Coverage Ratio = 0.98 (Ebit TTM 388.1m / Interest Expense TTM 396.5m)
EV/FCF = 15.24x (Enterprise Value 5.54b / FCF TTM 363.3m)
FCF Yield = 6.56% (FCF TTM 363.3m / Enterprise Value 5.54b)
FCF Margin = 12.65% (FCF TTM 363.3m / Revenue TTM 2.87b)
Net Margin = -6.71% (Net Income TTM -192.7m / Revenue TTM 2.87b)
Gross Margin = 30.23% ((Revenue TTM 2.87b - Cost of Revenue TTM 2.00b) / Revenue TTM)
Gross Margin QoQ = 10.33% (prev 35.49%)
Tobins Q-Ratio = 0.58 (Enterprise Value 5.54b / Total Assets 9.56b)
Interest Expense / Debt = 1.92% (Interest Expense 84.3m / Debt 4.39b)
Taxrate = 25.0% (EU avg default 25%)
NOPAT = 291.1m (EBIT 388.1m * (1 - 25.00%))
Current Ratio = 1.33 (Total Current Assets 1.37b / Total Current Liabilities 1.03b)
Debt / Equity = 1.13 (Debt 4.39b / totalStockholderEquity, last quarter 3.88b)
Debt / EBITDA = 6.69 (Net Debt 3.54b / EBITDA 528.6m)
Debt / FCF = 9.74 (Net Debt 3.54b / FCF TTM 363.3m)
Total Stockholder Equity = 4.14b (last 4 quarters mean from totalStockholderEquity)
RoA = -1.89% (Net Income -192.7m / Total Assets 9.56b)
RoE = -4.66% (Net Income TTM -192.7m / Total Stockholder Equity 4.14b)
RoCE = 5.24% (EBIT 388.1m / Capital Employed (Equity 4.14b + L.T.Debt 3.27b))
RoIC = 3.39% (NOPAT 291.1m / Invested Capital 8.58b)
WACC = 2.55% (E(1.51b)/V(5.90b) * Re(5.79%) + D(4.39b)/V(5.90b) * Rd(1.92%) * (1-Tc(0.25)))
Discount Rate = 5.79% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares Correlation 3-Years: 100.0 | Cagr: 0.09%
[DCF] Terminal Value 80.82% ; FCFF base≈363.3m ; Y1≈238.5m ; Y5≈109.1m
 [DCF] Fair Price = N/A (negative equity: EV 3.46b - Net Debt 3.54b = -75.4m; debt exceeds intrinsic value)
 EPS Correlation: -63.04 | EPS CAGR: -6.99% | SUE: -1.57 | # QB: 0
Revenue Correlation: 8.28 | Revenue CAGR: 17.79% | SUE: 0.06 | # QB: 0
EPS current Year (2026-12-31): EPS=2.82 | Chg7d=+0.000 | Chg30d=-0.005 | Revisions Net=-3 | Growth EPS=-20.9% | Growth Revenue=-13.5%
EPS next Year (2027-12-31): EPS=2.69 | Chg7d=-0.003 | Chg30d=-0.004 | Revisions Net=-1 | Growth EPS=-4.9% | Growth Revenue=+10.8%
[Analyst] Revisions Ratio: -0.60 (1 Up / 4 Down within 30d for Current Year)